Teva Pharmaceutical Industries ADR (NY: TEVA )

17.07 +0.27 (+1.58%)

Streaming Delayed Price Updated: 2:44 PM EDT, Jul 22, 2024 Add to My Watchlist

Price and Volume

Volume	4,042,239
Open	16.78
Bid (Size)	17.07 (23)
Ask (Size)	17.08 (16)
Prev. Close	16.81
Today's Range	16.78 - 17.18
52wk Range	8.055 - 17.69
Shares Outstanding	1,110,352,397
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

$100 Invested In This Stock 5 Years Ago Would Be Worth $200 Today

July 19, 2024

Via Benzinga

Teva's Migraine Treatment Found Effective For Children As Young As 6

July 18, 2024

Teva Pharmaceutical's Phase 3 SPACE study reveals Ajovy's significant efficacy in preventing episodic migraines in children aged 6-17. The trial's primary endpoint was met with safety data aligning...

Via Benzinga

Performance

YTD	+60.03%	+60.03%
1 Month	+0.68%	+0.68%
3 Month	+32.57%	+32.57%
6 Month	+48.61%	+48.61%
1 Year	+97.63%	+97.63%

More News

Teva Announces First Phase 3 Evidence of Efficacy and Safety of an Anti-CGRP Monoclonal Antibody in Children in AJOVY® (fremanezumab) SPACE Trial for Prevention of Episodic Migraine

July 18, 2024

From Teva Pharmaceutical Industries Limited

Via Business Wire

Jim Cramer Says Don't Sell Match Group: 'You've Just Got A Very, Very Smart Investor In There'

July 17, 2024

Via Benzinga

Breaking Down Teva Pharmaceutical Indus: 5 Analysts Share Their Views

June 27, 2024

Via Benzinga

If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,100 Today

June 12, 2024

Via Benzinga

4 Analysts Assess Teva Pharmaceutical Indus: What You Need To Know

May 30, 2024

Via Benzinga

3 No-Brainer Stocks to Buy With $200 Right Now

July 17, 2024

Via The Motley Fool

Here's How Much $1000 Invested In Teva Pharmaceutical Indus 5 Years Ago Would Be Worth Today

July 16, 2024

Via Benzinga

Teva Pharmaceuticals Stock: Unlock Value in This Generic Drug Gem

July 10, 2024

Via MarketBeat

Teva to Host Conference Call to Discuss Second Quarter 2024 Financial Results at 8 a.m. ET on July 31, 2024

July 02, 2024

From Teva Pharmaceutical Industries Limited

Via Business Wire

FTC Crackdown on Teva Pharmaceuticals Over Inhaler Patent Abuse

July 01, 2024

Via Benzinga

Dr. Reddy's Labs Stock Sees Improved Technical Strength

June 28, 2024

Via Investor's Business Daily

New AJOVY® (fremanezumab) Migraine Prevention Data Challenges Treatment Pauses

June 28, 2024

From Teva Pharmaceutical Industries Limited

Via Business Wire

Teva Reaches Agreement With the Israel Tax Authority to Resolve All Pending Litigation for the Company's Taxable Years 2008-2020

June 25, 2024

From Teva Pharmaceutical Industries Limited

Via Business Wire

Teva Announces Launch of Authorized Generic of Victoza® (liraglutide injection 1.8mg), in the United States

June 24, 2024

From Teva Pharmaceutical Industries Limited

Via Business Wire

Teva Engages In Settlement Talks Over Medicare Kickback Allegations

June 18, 2024

Via Benzinga

Concerpt Therapeutics Shares Are Trading Lower: What You Need To Know

June 14, 2024

Via Benzinga

7 A-Rated Biotech Stocks Worth Betting on in June

June 14, 2024

Via InvestorPlace

What is a Bull Flag Pattern? Explanation and Examples

June 13, 2024

Via MarketBeat

Teva to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

June 04, 2024

From Teva Pharmaceutical Industries Limited

Via Business Wire

New Data Provide Schizophrenia Treatment Insights into Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension from Invega Sustenna® (paliperidone palmitate)

June 01, 2024

From Teva Pharmaceutical Industries Limited

Via Business Wire

Teva Presents First Real-World Data from the IMPACT-TD Registry Study at Psych Congress Elevate 2024

June 01, 2024

From Teva Pharmaceutical Industries Limited

Via Business Wire

2 Generic Drug Makers With Growing Runways

May 31, 2024

Via MarketBeat

Teva Announces AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets Now U.S. FDA Approved as a One Pill, Once-Daily Treatment Option for Clinically Therapeutic Doses (24–48 mg/day)

May 29, 2024

From Teva Pharmaceutical Industries Limited

Via Business Wire

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.